Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-02-25 @ 11:03 PM
Study NCT ID:
NCT00501332
Status:
UNKNOWN
Last Update Posted:
2007-12-24
First Post:
2007-07-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Sponsor:
Maxygen Holdings Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MP-CL-30166
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Santosh Vetticaden, MD. Chief Medical Officer.
Old Organization:
Maxygen, Inc.